Media Summary: The era of human scientists is ending. Ginkgo Bioworks CEO Jason Kelly reveals how AI, robotics, and full lab automation are ... What if the next medical revolution is not another pill, but an electrical signal? For more than a century, Big Pharma has been built ... [Hook] Is the market entirely wrong about ANTEROGEN? We just uncovered what might be the greatest deep-value mispricing ...

Billiontoone Is Solving One Of Biotech S Hardest Problems - Detailed Analysis & Overview

The era of human scientists is ending. Ginkgo Bioworks CEO Jason Kelly reveals how AI, robotics, and full lab automation are ... What if the next medical revolution is not another pill, but an electrical signal? For more than a century, Big Pharma has been built ... [Hook] Is the market entirely wrong about ANTEROGEN? We just uncovered what might be the greatest deep-value mispricing ... Formation Bio CEO Benjamine Liu joins 'Fast Money' as Formation comes in at on the Disruptor 50 list. RNAi and exon-skipping therapies headline the list of regulatory and pivotal data catalysts in 2026, while new lipid-lowering ... Barbara Doran, CIO & Senior Portfolio Manager at BD8 Capital Partners, says Fed independence is key, highlights consumer ...

Photo Gallery

BillionToOne Is Solving One of Biotech’s Hardest Problems
Saving Millions of Lives Using Blood to Catch Cancer Early, with BillionToOne founder Oguzhan Atay
Unity by BillionToOne | Unveiling the Innovation of the Decade in Prenatal Genetics
Unity by BillionToOne | Unveiling the Innovation of the Decade in Prenatal Genetics
FDA Approval Drama: What Billions Reveals About Biotech Stocks! 📈📉 #Billions
$100 Trillion Future of Biotech: AI, China & Next Industrial Revolution | CEO Ginkgo Bioworks
Bioelectronics Will Destroy Big Pharma's Monopoly
BillionToOne Soars 67%! Smart Biotech Bet or Bubble?
AI Solved A Biology Problem Scientists Couldn’t Crack 😵
​I Found the Most Undervalued Biotech Company in the World
CNBC Disruptor 50: Formation Bio CEO Benjamine Liu on using AI for drug development
Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules
Sponsored
Sponsored
View Detailed Profile
BillionToOne Is Solving One of Biotech’s Hardest Problems

BillionToOne Is Solving One of Biotech’s Hardest Problems

1

Saving Millions of Lives Using Blood to Catch Cancer Early, with BillionToOne founder Oguzhan Atay

Saving Millions of Lives Using Blood to Catch Cancer Early, with BillionToOne founder Oguzhan Atay

Oguzhan Atay is the founder & CEO of

Sponsored
Unity by BillionToOne | Unveiling the Innovation of the Decade in Prenatal Genetics

Unity by BillionToOne | Unveiling the Innovation of the Decade in Prenatal Genetics

Join

Unity by BillionToOne | Unveiling the Innovation of the Decade in Prenatal Genetics

Unity by BillionToOne | Unveiling the Innovation of the Decade in Prenatal Genetics

Join

FDA Approval Drama: What Billions Reveals About Biotech Stocks! 📈📉 #Billions

FDA Approval Drama: What Billions Reveals About Biotech Stocks! 📈📉 #Billions

FDA approval could make or break

Sponsored
$100 Trillion Future of Biotech: AI, China & Next Industrial Revolution | CEO Ginkgo Bioworks

$100 Trillion Future of Biotech: AI, China & Next Industrial Revolution | CEO Ginkgo Bioworks

The era of human scientists is ending. Ginkgo Bioworks CEO Jason Kelly reveals how AI, robotics, and full lab automation are ...

Bioelectronics Will Destroy Big Pharma's Monopoly

Bioelectronics Will Destroy Big Pharma's Monopoly

What if the next medical revolution is not another pill, but an electrical signal? For more than a century, Big Pharma has been built ...

BillionToOne Soars 67%! Smart Biotech Bet or Bubble?

BillionToOne Soars 67%! Smart Biotech Bet or Bubble?

Biotech

AI Solved A Biology Problem Scientists Couldn’t Crack 😵

AI Solved A Biology Problem Scientists Couldn’t Crack 😵

For decades,

​I Found the Most Undervalued Biotech Company in the World

​I Found the Most Undervalued Biotech Company in the World

[Hook] Is the market entirely wrong about ANTEROGEN? We just uncovered what might be the greatest deep-value mispricing ...

CNBC Disruptor 50: Formation Bio CEO Benjamine Liu on using AI for drug development

CNBC Disruptor 50: Formation Bio CEO Benjamine Liu on using AI for drug development

Formation Bio CEO Benjamine Liu joins 'Fast Money' as Formation comes in at #37 on the Disruptor 50 list.

Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules

Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules

RNAi and exon-skipping therapies headline the list of regulatory and pivotal data catalysts in 2026, while new lipid-lowering ...

This Beaten Down Biotech Stock Has A Secret Billionaire Backer

This Beaten Down Biotech Stock Has A Secret Billionaire Backer

This Beaten Down

Billion To One Corporate Video | Transforming Healthcare with Genetic Testing

Billion To One Corporate Video | Transforming Healthcare with Genetic Testing

Discover how

Doran: Biotech has tremendous opportunity with AI accelerating innovation

Doran: Biotech has tremendous opportunity with AI accelerating innovation

Barbara Doran, CIO & Senior Portfolio Manager at BD8 Capital Partners, says Fed independence is key, highlights consumer ...

What $12 Billion in Biotech Exits Taught This CEO About Relationships, Risk, and Near-Death

What $12 Billion in Biotech Exits Taught This CEO About Relationships, Risk, and Near-Death

What does it actually take to build a

No More Phase 3 Trials? Biosimilars Get Faster Approval | Jake Knurek of Mabion Biologics- A Podcast

No More Phase 3 Trials? Biosimilars Get Faster Approval | Jake Knurek of Mabion Biologics- A Podcast

In this episode of